Bacterial proteomics and its role in antibacterial drug discovery

Mass Spectrometry Reviews
Heike Brötz-OesterheltHarald Labischinski

Abstract

Gene-expression profiling technologies in general, and proteomic technologies in particular have proven extremely useful to study the physiological response of bacterial cells to various environmental stress conditions. Complex protein toolkits coordinated by sophisticated regulatory networks have evolved to accommodate bacterial survival under ever-present stress conditions such as varying temperatures, nutrient availability, or antibiotics produced by other microorganisms that compete for habitat. In the last decades, application of man-made antibacterial agents resulted in additional bacterial exposure to antibiotic stress. Whereas the targeted use of antibiotics has remarkably reduced human suffering from infectious diseases, the ever-increasing emergence of bacteria that are resistant to antibiotics has led to an urgent need for novel antibiotic strategies. The intent of this review is to present an overview of the major achievements of proteomic approaches to study adaptation networks that are crucial for bacterial survival with a special emphasis on the stress induced by antibiotic treatment. A further focus will be the review of the, so far few, published efforts to exploit the knowledge derived from bacterial proteomic...Continue Reading

References

Aug 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·R A VanBogelen, F C Neidhardt
Nov 1, 1986·Journal of Bacteriology·S L GomesA M Silva
Mar 1, 1967·European Journal of Biochemistry·P Edman, G Begg
Mar 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·J H Krueger, G C Walker
Jul 1, 1995·Electrophoresis·V C WasingerI Humphery-Smith
Jul 28, 1995·Science·R D FleischmannJ M Merrick
Jan 1, 1995·Methods in Enzymology·N S Kosower, E M Kosower
Sep 1, 1993·Archives of Biochemistry and Biophysics·J M SilvaP J O'Brien
Jun 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·W J HenzelC Watanabe
Feb 1, 1996·Molecular Microbiology·M HeckerU Völker
Jan 19, 1999·JAMA : the Journal of the American Medical Association·G L ArmstrongR W Pinner
Jun 9, 1999·Proceedings of the National Academy of Sciences of the United States of America·Y OdaB T Chait
Sep 24, 1999·Electrophoresis·R A VanBogelenF C Neidhardt
Feb 16, 2000·Electrophoresis·H LangenM Fountoulakis
Apr 29, 2000·Electrophoresis·G L CorthalsJ C Sanchez
Nov 28, 2000·Annual Review of Genetics·M D SuttonG C Walker
Feb 24, 2001·Cellular and Molecular Life Sciences : CMLS·C P Gray, W Keck
Feb 27, 2001·Mass Spectrometry Reviews·J Godovac-Zimmermann, L R Brown
Mar 20, 2001·Current Pharmaceutical Design·M YoshidaR A Lepleya
Mar 21, 2001·Antimicrobial Agents and Chemotherapy·C M ApfelW Keck
May 19, 2001·Electrophoresis·B B VandahlK Gevaert
Jun 8, 2001·Annual Review of Biochemistry·M MannA Pandey
Jun 16, 2001·Advances in Microbial Physiology·M Hecker, U Völker

❮ Previous
Next ❯

Citations

Sep 21, 2011·The Journal of Antimicrobial Chemotherapy·Tina Wecke, Thorsten Mascher
Mar 9, 2011·Antimicrobial Agents and Chemotherapy·Michaela WenzelJulia E Bandow
Jan 15, 2011·Clinical Microbiology Reviews·Lynn L Silver
Jan 21, 2014·International Journal of Medical Microbiology : IJMM·Andreas OttoDörte Becher
Nov 16, 2010·Future Microbiology·Heike Brötz-Oesterhelt, Peter Sass
Jun 5, 2012·Applied Microbiology and Biotechnology·Laurence Van OudenhoveBart Devreese
Feb 20, 2008·Expert Review of Proteomics·Haike AntelmannPeter Zuber
Dec 20, 2007·Expert Review of Molecular Diagnostics·Visith Thongboonkerd
Aug 1, 2008·Expert Opinion on Drug Discovery·Nishikant V Wase, Phillip C Wright
Mar 1, 2016·Frontiers in Microbiology·Shahper N Khan, Asad U Khan
Jul 26, 2006·Expert Opinion on Drug Metabolism & Toxicology·Frank A Witzmann, Matthew R Richardson
Jul 5, 2011·Proteomics·Michaela Wenzel, Julia E Bandow
Jan 1, 2014·Proteomics·Andreas OttoFrank Schmidt
May 9, 2006·Current Opinion in Microbiology·Stuart J Cordwell
Jun 21, 2007·Critical Reviews in Biotechnology·Lei NieWeiwen Zhang
Aug 1, 2007·Expert Opinion on Drug Discovery·Michael F Loughlin
Aug 1, 2015·Omics : a Journal of Integrative Biology·Nilay Budeyri Gokgoz, Berna Sariyar Akbulut
Jul 5, 2005·Drug Discovery Today·Christoph Freiberg, Heike Brötz-Oesterhelt
Jan 1, 2017·Journal of Global Antimicrobial Resistance·Van Chi ThaiThi Thu Hoai Nguyen
Aug 25, 2017·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Thomas EbenhanMike Sathekge
Aug 10, 2012·Current Protocols in Microbiology·Nadja Raatschen, Julia Elisabeth Bandow
Mar 20, 2019·Expert Opinion on Drug Discovery·Vladislav M ChernovRustam I Aminov
Jun 3, 2021·Antibiotics·Bernardo Ribeiro da CunhaCecília R C Calado
Mar 4, 2006·Journal of Proteome Research·Andrei P Sommer, Eleonora Gheorghiu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.